(redirected from Nizams)
Also found in: Dictionary.


see HyderabadHyderabad
, former princely state, S central India. The former princedom of Hyderabad is now divided among the states of Karnataka, Maharashtra, and Telangana. The Mughal empire conquered Hyderabad in the late 17th cent.
..... Click the link for more information.
, India.
References in periodicals archive ?
Such was its power that it flourished even under the Asaf Jahi dynasty's notorious miser, the seventh and last reigning Nizam, Mir Osman Ali Khan, who hardly ever spent anything on himself, though he was personally worth 2 per cent of the U.
Taste them with slices of their special breads - Sheermal (Dh16) and Bakarkhani (Dh14) and you will know why the Nizams loved their food
State BJP President G Kishan Reddy also lashed out at KCR saying he was behaving like the Nizam.
The Nizams ran a number of welfare activities in the 1930s and 1940s in Makkah and Madinah.
The state of Hyderabad at the time of Nizams was India's biggest and richest princely state, as large as England and Scotland put together.
Summary: The City of Nizams, Hyderabad, has made it to Lonely Planet's Top 10 Cities for 2013.
e appealed people to hold peaceful protest unless Nizams killers are arrested and punished.
He pointed out that the families (the Nizams, the Lahams, the Haffars, the Sabbaghs, the Midani Eibos, and the Meehs) are still inheriting the profession generation after generation.
The Nizams, who ruled the city, were great patrons of the gem and this, in turn, encouraged the merchants to procure the best pearls from Basra, Tahiti and some Gulf countries.
The Nizams, at the top, were clearly in charge and the Samasthans as well as other jagirdars that collected rent and tax were ultimately forced to fall in line with a feudal order that established the Nizams as the highest echelon.
Under the Nizams, the state attracted the best of minds and talent from across India and the world.
Raghunadharao Digumarti, professor of medical oncology at the Nizams Institute of Medical Sciences and a Phase II bavituximab cancer trial investigator who presented the data at ASCO on behalf of the study team.